- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03334383
Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery (SPONGE)
Randomized Controlled Trial to Evaluate the Effect of a Retractor Sponge in Postoperative Hospital Stay in Laparoscopic Colorectal Surgery in Patients With Malignancy
Study Overview
Detailed Description
Objective: We study the efficacy of the retractor sponge in laparoscopic colorectal surgery to reduce hospital stay in patients operated for a malignancy. Secondary objectives are duration of surgery, blood-loss, use of diuretics as volume therapy (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative complications.
Study design: Randomized controlled trial, nested within a prospective cohort according to the 'cohort multiple randomized controlled trial' (cmRCT) design.
Study population: Patients with colorectal cancer who undergo laparoscopic surgery, and who have given informed consent to be offered experimental interventions within the PICNIC project. Patient who require open surgery or patients with benign colorectal diseases are excluded for this study.
Intervention: Intraoperative use of the retractor sponge versus usual care, i.e. the Trendelenburg position.
Main study parameters/endpoints: The primary endpoint is length of hospital stay. Secondary endpoints are duration of surgery, blood-loss, use of diuretics (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative surgical, pulmonary and cardiac complications.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study will be conducted according to the cohort multiple Randomized Controlled Trial (cmRCT) design. Within the PICNIC cohort, we will identify all patients who are eligible for the experimental intervention (use of the sponge) and who have given informed consent to be invited for future experimental interventions. From this sub cohort, we will randomly select a group of patients to whom we will offer surgery with use of the retractor sponge, which they can accept or decline. Eligible patients from the sub cohort who were not randomly selected will undergo standard treatment, i.e. surgery in Trendelenburg position. We do not expect adverse events in patients in the intervention arm, besides dysfunction of the sponge, after which conversion to standard treatment (Trendelenburg position) needs to take place.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anke B Smits, MD
- Phone Number: 0031883201919
- Email: absmits@antoniusziekenhuis.nl
Study Contact Backup
- Name: Alice M Couwenberg, BSc
- Phone Number: 0031640904560
- Email: alice.couwenberg@gmail.com
Study Locations
-
-
Utrecht
-
Nieuwegein, Utrecht, Netherlands, 3430EM
- Recruiting
- St. Antonius Hospital
-
Contact:
- Alice M Couwenberg, BSc
- Phone Number: 0031640904560
- Email: alice.couwenberg@gmail.com
-
Contact:
- Anke B Smits, MD
- Phone Number: 088 3201919
- Email: absmits@antoniusziekenhuis.nl
-
Principal Investigator:
- Anke B Smits, MD/PhD
-
Sub-Investigator:
- Alice M Couwenberg, BSc
-
Sub-Investigator:
- Johannes PM Burbach, MD
-
Sub-Investigator:
- Helena M Verkooijen, MD/AssProf
-
Sub-Investigator:
- Peter G Noordzij, MD/PhD
-
Sub-Investigator:
- Onne Reerink, MD/PhD
-
Sub-Investigator:
- Marco van Vulpen, MD/Prof
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Participant in the PICNIC project (METC 12-510)
- Informed consent obtained for being offered experimental interventions within the PICNIC project
- Informed consent obtained for questionnaires on patient reported outcomes within the PICNIC project
- Planned for laparoscopic surgery of distal colorectal cancer in St. Antonius Hospital
Exclusion Criteria:
- Planned for open colorectal surgery
- Surgery for benign colorectal diseases
- Emergency colorectal surgery
- Inadequate understanding of the Dutch language in speech and/or writing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sponge group
Patients offered surgery with the retractor sponge
|
Compressed cellulose sponge for use in laparoscopic surgery to retract the intestines from the surgical field.
Other Names:
|
No Intervention: Control group
Patients receiving standard care: surgery in Trendelenburg position
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative hospital stay (days)
Time Frame: Up to 4 weeks
|
Based on a discharge checklist
|
Up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operation time
Time Frame: Up to 4 hours
|
minutes
|
Up to 4 hours
|
Blood-loss peroperative
Time Frame: During surgery time
|
ml
|
During surgery time
|
Diuretics peroperative and postoperative
Time Frame: Up to 4 weeks (during hospital stay)
|
mg
|
Up to 4 weeks (during hospital stay)
|
Postoperative hypoxemia
Time Frame: Up to 1 week
|
O2 saturation
|
Up to 1 week
|
Peri- and postoperative surgical complications
Time Frame: Up to 4 weeks
|
number
|
Up to 4 weeks
|
Pulmonary complications.
Time Frame: Up to 4 weeks
|
number
|
Up to 4 weeks
|
Cardiac complications
Time Frame: Up to 4 weeks
|
number
|
Up to 4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anke B Smits, MD, St. Antonius Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 49877 (Registry Identifier: CCMO (toetsingonline.nl): ABR form)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Carcinoma
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRecurrent Colon Carcinoma | Metastatic Colorectal Carcinoma | Stage IV Colon Cancer AJCC v7 | Stage IVA Colon Cancer AJCC v7 | Stage IVB Colon Cancer AJCC v7 | Refractory Colorectal CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingColon Carcinoma | Rectal CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
Nanfang Hospital of Southern Medical UniversityUnknownRectal Carcinoma | Sigmoid Colon CarcinomaChina
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Boehringer Ingelheim; National Comprehensive...CompletedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal... and other conditionsUnited States
-
Howard S. Hochster, MDRecruitingStage IV Colon Cancer AJCC v8 | Stage IVA Colon Cancer AJCC v8 | Stage IVB Colon Cancer AJCC v8 | Stage IVC Colon Cancer AJCC v8 | Metastatic Colon CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer | Colon Mucinous Adenocarcinoma | Colon Signet Ring Cell Adenocarcinoma | Rectal Mucinous Adenocarcinoma | Rectal Signet Ring Cell AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
Clinical Trials on Sponge
-
Fifth Affiliated Hospital of Guangzhou Medical...Not yet recruiting
-
Tehran University of Medical SciencesNational Cancer Institute (NCI); University of Cambridge; International Agency... and other collaboratorsActive, not recruitingEsophageal Cancer
-
Deep Life Medical LtdCompletedPain, PostoperativeTurkey
-
Mayo ClinicRecruitingBarrett Esophagus | Esophageal AdenocarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedGastroesophageal Reflux Disease | Metaplasia | Barrett Esophagus | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | DysplasiaUnited States
-
Changhai HospitalShanghai Municipal Science and Technology CommissionCompletedEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Twin Cities Spine CenterAllina Health SystemEnrolling by invitationSurgical Sponge, RetainedUnited States
-
University of ZurichUnknownEsophageal Cancer | Surgery--Complications | Leak, AnastomoticSwitzerland
-
Akdeniz UniversityCompletedPremature Birth | Preterm InfantTurkey